US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Vaxart, Inc.

0.6070

-0.0160-2.57%

Volume:296.95K

Turnover:178.22K

Market Cap:145.67M

PE:-2.73

High:0.6300

Open:0.5833

Low:0.5830

Close:0.6230

52wk High:0.8449

52wk Low:0.2850

Shares:239.98M

Float Shares:237.57M

Volume Ratio:0.60

T/O Rate:0.12%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.2222

EPS(LYR):-0.3312

ROE:-106.52%

ROA:-16.25%

PB:5.44

PE(LYR):-1.83

Loading ...

Overview Company News Filings

Vaxart announces publication in npj Vaccines on norovirus candidate

Vaxart Reports Positive Phase 1 Results for Oral Norovirus Vaccine in Lactating Women

Vaxart Publishes Positive Data for Its Oral Bivalent Norovirus Candidate in Lactating Women and Their Infants

THOMSON REUTERS

Vaxart Executives to Present at Global BioInnovation Forum

Vaxart Relocates Headquarters and Labs Within South San Francisco

Vaxart Inc. Director W. Mark Watson Acquires Common Shares

Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men

Vaxart Director Elaine J. Heron Reports Acquisition of Common Shares

Vaxart (OTC: VXRT) Q3 EPS $(0.04) Up From $(0.06) YoY, Sales $72.41M Up From $4.93M YoY

Vaxart to Host Upcoming Conference Calls

Dynavax reports Q3 HEPLISAV-B net product revenue of $90 million and announces $100 million share repurchase program

Vaxart Secures $30 Million From Dynavax for Oral COVID-19 Vaccine License

Vaxart Inc - to Receive $25 Mln Upfront and $5 Mln Equity Investment

THOMSON REUTERS

Vaxart Inc - May Receive up to $195 Mln in Regulatory Milestones

THOMSON REUTERS

Vaxart Inc - Dynavax to Pay Additional $50 Mln Fee to Vaxart

THOMSON REUTERS

Dynavax Enters Exclusive License Agreement for Vaxart's Novel Oral Covid-19 Vaccine Program

THOMSON REUTERS

Vaxart to Present Research on Second-Generation Norovirus Oral Pill Vaccine Candidate at IDWeek 2025

Vaxart Inc - Barda Intends to Conclusively Delimit Project Agreement to Exclude Paused Work - SEC Filing

THOMSON REUTERS

Vaxart Inc - 5,000 Participants in Trial to Continue Follow-up - SEC Filing

THOMSON REUTERS

Vaxart Inc - to Continue Receiving Funding for Participant Evaluation - SEC Filing

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/VXRT/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VXRT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VXRT\",,,,,undefined,":{"symbol":"VXRT","market":"US","secType":"STK","nameCN":"Vaxart, Inc.","latestPrice":0.607,"timestamp":1770411600000,"preClose":0.622995,"halted":0,"volume":296946,"delay":15,"changeRate":-0.025674363357651317,"floatShares":237569707,"shares":239979946,"eps":-0.222186,"marketStatus":"Market Closed","change":-0.015995,"latestTime":"02-06 16:00:00 EST Delay","open":0.5833,"high":0.63,"low":0.583,"amount":178222.87278900002,"amplitude":0.075442,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.222186,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"exchange":"OTCQX","adjPreClose":0.622995,"volumeRatio":0.6004661434286395},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VXRT\",,,,,undefined,":{"symbol":"VXRT","floatShares":237569707,"roa":"-16.25%","roe":"-106.52%","lyrEps":-0.3312,"volumeRatio":0.6004661434286395,"shares":239979946,"dividePrice":0,"high":0.63,"amplitude":0.075442,"preClose":0.622995,"low":0.583,"week52Low":0.285,"pbRate":"5.44","psRate":"0.98","week52High":0.8449,"institutionHeld":0.2085,"latestPrice":0.607,"eps":-0.222186,"divideRate":0,"volume":296946,"delay":15,"ttmEps":-0.222186,"open":0.5833,"prevYearClose":0.3464,"prevWeekClose":0.5798,"prevMonthClose":0.5798,"prevQuarterClose":0.3464,"fiveDayClose":0.5798,"twentyDayClose":0.4799,"sixtyDayClose":0.3982},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VXRT\",params:#limit:5,,,undefined,":[{"date":"2025-11-13","symbol":"VXRT","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1763067600000,"name":null,"time":"Post Market","dateTimestamp":1763010000000,"actualEps":null},{"date":"2025-08-13","symbol":"VXRT","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755115200000,"name":null,"time":"Post Market","dateTimestamp":1755057600000,"actualEps":null},{"market":"US","date":"2025-07-08","symbol":"VXRT","reason":null,"defaultRemindTime":1751981400000,"announcedDate":"2025-07-07","type":"delisting","dateTimestamp":1751947200000},{"market":"US","date":"2025-05-13","symbol":"VXRT","fiscalQuarterEnding":"2025/03","expectedEps":-0.07,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"post","actualEps":-0.07},{"market":"US","date":"2025-03-20","symbol":"VXRT","fiscalQuarterEnding":"2024/12","expectedEps":-0.1,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742443200000,"reportTimeType":"post","actualEps":-0.05}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VXRT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VXRT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6667,"buy":0.3333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6667,"analysts":3,"updateTime":1723611600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VXRT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VXRT","date":"2025-07-07","current":-1.676666,"percent":0.701954,"low":-105.751188,"twenty":-19.816045,"median":-2.524865,"eighty":-1.331416,"high":-0.748647,"avg":-10.373929,"sd":14.337027,"marketCap":97451200},"quantilePoints":[{"date":"2021-02-12","current":-37.479678,"twenty":-24.621357,"median":-3.007394,"eighty":-0.720539,"marketCap":928296653},{"date":"2021-02-19","current":-32.971509,"twenty":-24.951714,"median":-3.035241,"eighty":-0.723883,"marketCap":816638329},{"date":"2021-02-26","current":-26.133821,"twenty":-25.254584,"median":-3.056143,"eighty":-0.727271,"marketCap":842031704},{"date":"2021-03-05","current":-22.003581,"twenty":-25.385697,"median":-3.071702,"eighty":-0.728417,"marketCap":708955365},{"date":"2021-03-12","current":-24.635238,"twenty":-25.300543,"median":-3.111083,"eighty":-0.72875,"marketCap":793747369},{"date":"2021-03-19","current":-25.146949,"twenty":-25.307772,"median":-3.167341,"eighty":-0.729291,"marketCap":810234703},{"date":"2021-03-26","current":-21.893928,"twenty":-25.285923,"median":-3.209191,"eighty":-0.740156,"marketCap":705422365},{"date":"2021-04-01","current":-22.295987,"twenty":-25.263424,"median":-3.251448,"eighty":-0.748153,"marketCap":718376699},{"date":"2021-04-09","current":-20.212591,"twenty":-25.219226,"median":-3.285857,"eighty":-0.749779,"marketCap":651249696},{"date":"2021-04-16","current":-19.554677,"twenty":-25.174404,"median":-3.301692,"eighty":-0.751488,"marketCap":630051695},{"date":"2021-04-23","current":-20.322244,"twenty":-25.146949,"median":-3.324864,"eighty":-0.753907,"marketCap":654782696},{"date":"2021-04-30","current":-39.467752,"twenty":-25.263424,"median":-3.447532,"eighty":-0.755184,"marketCap":1271650971},{"date":"2021-05-07","current":-18.758424,"twenty":-25.219226,"median":-3.480781,"eighty":-0.756696,"marketCap":880332861},{"date":"2021-05-14","current":-17.221276,"twenty":-25.174404,"median":-3.562793,"eighty":-0.757465,"marketCap":808194474},{"date":"2021-05-21","current":-17.455756,"twenty":-25.146949,"median":-3.668949,"eighty":-0.758534,"marketCap":819198635},{"date":"2021-05-28","current":-17.247329,"twenty":-25.132329,"median":-3.716314,"eighty":-0.762241,"marketCap":809417158},{"date":"2021-06-04","current":-17.898663,"twenty":-25.100341,"median":-3.740207,"eighty":-0.765396,"marketCap":839984272},{"date":"2021-06-11","current":-22.770643,"twenty":-25.040769,"median":-3.784911,"eighty":-0.765396,"marketCap":1068626279},{"date":"2021-06-18","current":-20.321627,"twenty":-24.959495,"median":-3.818439,"eighty":-0.766189,"marketCap":953693933},{"date":"2021-06-25","current":-22.249576,"twenty":-24.923978,"median":-3.823686,"eighty":-0.769368,"marketCap":1044172588},{"date":"2021-07-02","current":-19.487919,"twenty":-24.802373,"median":-3.838928,"eighty":-0.770179,"marketCap":914568028},{"date":"2021-07-09","current":-19.175278,"twenty":-24.635238,"median":-3.855691,"eighty":-0.773328,"marketCap":899895814},{"date":"2021-07-16","current":-18.654211,"twenty":-24.634237,"median":-3.874318,"eighty":-0.775124,"marketCap":875442123},{"date":"2021-07-23","current":-21.207441,"twenty":-24.618137,"median":-3.904222,"eighty":-0.779495,"marketCap":995265207},{"date":"2021-07-30","current":-18.732371,"twenty":-24.54483,"median":-3.911571,"eighty":-0.780536,"marketCap":879110177},{"date":"2021-08-06","current":-19.875682,"twenty":-24.534704,"median":-3.922747,"eighty":-0.783658,"marketCap":1074658243},{"date":"2021-08-13","current":-19.648531,"twenty":-24.196628,"median":-3.993528,"eighty":-0.784699,"marketCap":1062376435},{"date":"2021-08-20","current":-18.944364,"twenty":-23.987277,"median":-4.032643,"eighty":-0.785264,"marketCap":1024302828},{"date":"2021-08-27","current":-20.557134,"twenty":-23.83112,"median":-4.164892,"eighty":-0.789902,"marketCap":1111503669},{"date":"2021-09-03","current":-19.784822,"twenty":-23.788212,"median":-4.379596,"eighty":-0.793157,"marketCap":1069745520},{"date":"2021-09-10","current":-19.898397,"twenty":-23.532839,"median":-4.462883,"eighty":-0.794639,"marketCap":1075886424},{"date":"2021-09-17","current":-19.48492,"twenty":-23.407808,"median":-4.598977,"eighty":-0.805035,"marketCap":1053530161},{"date":"2021-09-24","current":-18.92887,"twenty":-23.275549,"median":-4.749204,"eighty":-0.810437,"marketCap":1023465091},{"date":"2021-10-01","current":-16.635164,"twenty":-23.027951,"median":-4.822538,"eighty":-0.812621,"marketCap":899446677},{"date":"2021-10-08","current":-16.194958,"twenty":-22.928552,"median":-4.854475,"eighty":-0.819992,"marketCap":875645163},{"date":"2021-10-15","current":-16.079114,"twenty":-22.91735,"median":-4.886413,"eighty":-0.832658,"marketCap":869381607},{"date":"2021-10-22","current":-15.615739,"twenty":-22.799984,"median":-4.910366,"eighty":-0.835387,"marketCap":844327382},{"date":"2021-10-29","current":-15.546233,"twenty":-22.770643,"median":-4.934319,"eighty":-0.847417,"marketCap":840569248},{"date":"2021-11-05","current":-13.187876,"twenty":-22.749801,"median":-4.934319,"eighty":-0.850966,"marketCap":838313720},{"date":"2021-11-12","current":-13.444526,"twenty":-22.475519,"median":-4.966256,"eighty":-0.858579,"marketCap":854628209},{"date":"2021-11-19","current":-13.8986,"twenty":-22.364681,"median":-4.979271,"eighty":-0.86136,"marketCap":883492304},{"date":"2021-11-26","current":-14.767262,"twenty":-22.319108,"median":-4.982225,"eighty":-0.861588,"marketCap":938710573},{"date":"2021-12-03","current":-12.477152,"twenty":-22.274853,"median":-4.998193,"eighty":-0.862241,"marketCap":793135137},{"date":"2021-12-10","current":-12.279729,"twenty":-22.254051,"median":-5.022146,"eighty":-0.862844,"marketCap":780585530},{"date":"2021-12-17","current":-14.214477,"twenty":-22.189701,"median":-5.094005,"eighty":-0.863122,"marketCap":903571675},{"date":"2021-12-23","current":-13.622207,"twenty":-22.135164,"median":-5.094005,"eighty":-0.863234,"marketCap":865922855},{"date":"2021-12-31","current":-12.378441,"twenty":-22.091303,"median":-5.15788,"eighty":-0.863902,"marketCap":786860333},{"date":"2022-01-07","current":-12.042821,"twenty":-22.042748,"median":-5.173849,"eighty":-0.867577,"marketCap":765526002},{"date":"2022-01-14","current":-11.588747,"twenty":-22.012988,"median":-5.309582,"eighty":-0.871699,"marketCap":736661907},{"date":"2022-01-21","current":-9.466447,"twenty":-21.98165,"median":-5.517175,"eighty":-0.872924,"marketCap":601753636},{"date":"2022-01-28","current":-9.061729,"twenty":-21.893928,"median":-5.643705,"eighty":-0.877749,"marketCap":576026942},{"date":"2022-02-04","current":-9.476318,"twenty":-21.850423,"median":-5.779516,"eighty":-0.881043,"marketCap":602381116},{"date":"2022-02-11","current":-9.653999,"twenty":-21.668736,"median":-6.33785,"eighty":-0.885403,"marketCap":613675762},{"date":"2022-02-18","current":-9.377607,"twenty":-21.635317,"median":-6.373465,"eighty":-0.888299,"marketCap":596106313},{"date":"2022-02-25","current":-9.301435,"twenty":-21.624295,"median":-6.411402,"eighty":-0.889427,"marketCap":655472147},{"date":"2022-03-04","current":-7.819633,"twenty":-21.624295,"median":-6.449339,"eighty":-0.889548,"marketCap":551049521},{"date":"2022-03-11","current":-7.962457,"twenty":-21.572188,"median":-6.503105,"eighty":-0.89108,"marketCap":561114352},{"date":"2022-03-18","current":-9.390701,"twenty":-21.494028,"median":-6.525214,"eighty":-0.894143,"marketCap":661762667},{"date":"2022-03-25","current":-8.908668,"twenty":-21.455319,"median":-6.657994,"eighty":-0.896267,"marketCap":627793861},{"date":"2022-04-01","current":-9.283582,"twenty":-21.389815,"median":-6.828712,"eighty":-0.898181,"marketCap":654214043},{"date":"2022-04-08","current":-8.408783,"twenty":-21.207441,"median":-6.948211,"eighty":-0.89832,"marketCap":592566951},{"date":"2022-04-14","current":-8.319518,"twenty":-21.171818,"median":-7.062176,"eighty":-0.89858,"marketCap":586276431},{"date":"2022-04-22","current":-6.923889,"twenty":-21.133671,"median":-7.192952,"eighty":-0.902351,"marketCap":487926430},{"date":"2022-04-29","current":-6.242262,"twenty":-21.06788,"median":-7.062176,"eighty":-0.904212,"marketCap":439892222},{"date":"2022-05-06","current":-6.385763,"twenty":-21.051549,"median":-7.018399,"eighty":-0.904892,"marketCap":450004687},{"date":"2022-05-13","current":-5.308041,"twenty":-21.037544,"median":-6.900956,"eighty":-0.90634,"marketCap":422329008},{"date":"2022-05-20","current":-5.91195,"twenty":-20.943513,"median":-6.828712,"eighty":-0.910562,"marketCap":470378416},{"date":"2022-05-27","current":-5.927843,"twenty":-20.920631,"median":-6.753747,"eighty":-0.913548,"marketCap":471642875},{"date":"2022-06-03","current":-5.800704,"twenty":-20.858215,"median":-6.666925,"eighty":-0.916976,"marketCap":461527210},{"date":"2022-06-10","current":-5.101441,"twenty":-20.805099,"median":-6.563151,"eighty":-0.920534,"marketCap":405891053},{"date":"2022-06-17","current":-4.95841,"twenty":-20.762274,"median":-6.522073,"eighty":-0.921726,"marketCap":394510930},{"date":"2022-06-24","current":-6.007304,"twenty":-20.738704,"median":-6.481364,"eighty":-0.923659,"marketCap":477965165},{"date":"2022-07-01","current":-5.959627,"twenty":-20.732809,"median":-6.449339,"eighty":-0.926438,"marketCap":474171791},{"date":"2022-07-08","current":-7.119768,"twenty":-20.716717,"median":-6.47545,"eighty":-0.926749,"marketCap":566477233},{"date":"2022-07-15","current":-6.801921,"twenty":-20.672029,"median":-6.522073,"eighty":-0.928631,"marketCap":541188071},{"date":"2022-07-22","current":-5.943735,"twenty":-20.608152,"median":-6.518932,"eighty":-0.931278,"marketCap":472907333},{"date":"2022-07-29","current":-5.848381,"twenty":-20.577155,"median":-6.466482,"eighty":-0.932581,"marketCap":465320584},{"date":"2022-08-05","current":-6.531752,"twenty":-20.556929,"median":-6.449339,"eighty":-0.936915,"marketCap":519692283},{"date":"2022-08-12","current":-5.66621,"twenty":-20.547226,"median":-6.449339,"eighty":-0.940199,"marketCap":526266245},{"date":"2022-08-19","current":-4.971554,"twenty":-20.502618,"median":-6.373465,"eighty":-0.942198,"marketCap":461748027},{"date":"2022-08-26","current":-4.167933,"twenty":-20.466274,"median":-6.373465,"eighty":-0.944184,"marketCap":387109305},{"date":"2022-09-02","current":-3.881899,"twenty":-20.463398,"median":-6.293366,"eighty":-0.945331,"marketCap":360542980},{"date":"2022-09-09","current":-3.90914,"twenty":-20.451893,"median":-6.242262,"eighty":-0.946787,"marketCap":363073106},{"date":"2022-09-16","current":-3.527761,"twenty":-20.42584,"median":-6.064906,"eighty":-0.953734,"marketCap":327651340},{"date":"2022-09-23","current":-2.860346,"twenty":-20.420843,"median":-6.023197,"eighty":-0.955683,"marketCap":265663248},{"date":"2022-09-30","current":-2.969312,"twenty":-20.358795,"median":-5.97552,"eighty":-0.956859,"marketCap":275783753},{"date":"2022-10-07","current":-2.628795,"twenty":-20.34768,"median":-5.959627,"eighty":-0.960974,"marketCap":244157176},{"date":"2022-10-14","current":-2.315518,"twenty":-20.329983,"median":-5.943735,"eighty":-0.961895,"marketCap":215060725},{"date":"2022-10-21","current":-2.274656,"twenty":-20.322244,"median":-5.925003,"eighty":-0.963496,"marketCap":211265536},{"date":"2022-10-28","current":-2.356381,"twenty":-20.321627,"median":-5.872219,"eighty":-0.966265,"marketCap":218855914},{"date":"2022-11-04","current":-2.002242,"twenty":-20.321627,"median":-5.843279,"eighty":-0.976011,"marketCap":185964274},{"date":"2022-11-11","current":-2.082841,"twenty":-20.307268,"median":-5.800704,"eighty":-0.977003,"marketCap":217873482},{"date":"2022-11-18","current":-1.706424,"twenty":-20.295573,"median":-5.784812,"eighty":-0.982039,"marketCap":178498756},{"date":"2022-11-25","current":-1.606046,"twenty":-20.229187,"median":-5.689458,"eighty":-0.985733,"marketCap":167998830},{"date":"2022-12-02","current":-1.63114,"twenty":-20.197473,"median":-5.65956,"eighty":-0.988165,"marketCap":170623811},{"date":"2022-12-09","current":-1.292365,"twenty":-20.179571,"median":-5.609996,"eighty":-0.991398,"marketCap":135186558},{"date":"2022-12-16","current":-1.330007,"twenty":-20.162556,"median":-5.583585,"eighty":-0.996141,"marketCap":139124031},{"date":"2022-12-23","current":-1.036402,"twenty":-20.077759,"median":-5.543624,"eighty":-0.997169,"marketCap":108411745},{"date":"2022-12-30","current":-1.205664,"twenty":-20.040863,"median":-5.525159,"eighty":-0.995134,"marketCap":126117246},{"date":"2023-01-06","current":-1.222477,"twenty":-20.021497,"median":-5.49875,"eighty":-0.997158,"marketCap":127875984},{"date":"2023-01-13","current":-1.468026,"twenty":-20.001094,"median":-5.466964,"eighty":-0.998065,"marketCap":153561430},{"date":"2023-01-20","current":-1.417837,"twenty":-19.97236,"median":-5.427233,"eighty":-1.000258,"marketCap":148311467},{"date":"2023-01-27","current":-1.392743,"twenty":-19.903498,"median":-5.365473,"eighty":-1.004552,"marketCap":145686485},{"date":"2023-02-03","current":-1.355101,"twenty":-19.893854,"median":-5.308041,"eighty":-1.009886,"marketCap":141749012},{"date":"2023-02-10","current":-1.180695,"twenty":-19.866307,"median":-5.28483,"eighty":-1.020314,"marketCap":123505389},{"date":"2023-02-17","current":-1.242804,"twenty":-19.847558,"median":-5.253692,"eighty":-1.026357,"marketCap":130002219},{"date":"2023-02-24","current":-1.012562,"twenty":-19.847558,"median":-5.253692,"eighty":-1.0154,"marketCap":105918012},{"date":"2023-03-03","current":-1.094997,"twenty":-19.847558,"median":-5.253692,"eighty":-1.00197,"marketCap":114541077},{"date":"2023-03-10","current":-0.955974,"twenty":-19.847558,"median":-5.253692,"eighty":-0.997164,"marketCap":99998678},{"date":"2023-03-17","current":-0.977355,"twenty":-19.847558,"median":-5.253692,"eighty":-0.990155,"marketCap":105317845},{"date":"2023-03-24","current":-0.952824,"twenty":-19.847558,"median":-5.253692,"eighty":-0.977701,"marketCap":102674392},{"date":"2023-03-31","current":-0.951943,"twenty":-19.838183,"median":-5.229739,"eighty":-0.975165,"marketCap":102579499},{"date":"2023-04-06","current":-0.936218,"twenty":-19.838183,"median":-5.229739,"eighty":-0.961711,"marketCap":100884979},{"date":"2023-04-14","current":-0.859227,"twenty":-19.847558,"median":-5.253692,"eighty":-0.955858,"marketCap":92588606},{"date":"2023-04-21","current":-0.857718,"twenty":-19.847558,"median":-5.253692,"eighty":-0.951943,"marketCap":92425932},{"date":"2023-04-28","current":-0.965404,"twenty":-19.847558,"median":-5.253692,"eighty":-0.944738,"marketCap":104030009},{"date":"2023-05-05","current":-1.082181,"twenty":-19.847558,"median":-5.253692,"eighty":-0.944738,"marketCap":116613691},{"date":"2023-05-12","current":-1.308211,"twenty":-19.847558,"median":-5.253692,"eighty":-0.944738,"marketCap":141021208},{"date":"2023-05-19","current":-1.635264,"twenty":-19.847558,"median":-5.15788,"eighty":-0.944738,"marketCap":176276510},{"date":"2023-05-26","current":-1.522053,"twenty":-19.856932,"median":-5.109387,"eighty":-0.944624,"marketCap":164072752},{"date":"2023-06-02","current":-1.572369,"twenty":-19.856932,"median":-5.070053,"eighty":-0.944624,"marketCap":169496645},{"date":"2023-06-09","current":-1.265549,"twenty":-19.856932,"median":-5.006177,"eighty":-0.944624,"marketCap":136422424},{"date":"2023-06-16","current":-1.226454,"twenty":-19.856932,"median":-4.982225,"eighty":-0.944624,"marketCap":132208019},{"date":"2023-06-23","current":-1.358929,"twenty":-19.866307,"median":-4.976316,"eighty":-0.944509,"marketCap":146488486},{"date":"2023-06-30","current":-1.065992,"twenty":-19.875682,"median":-4.979271,"eighty":-0.944395,"marketCap":114910765},{"date":"2023-07-07","current":-1.013536,"twenty":-19.880225,"median":-4.974302,"eighty":-0.944314,"marketCap":109256185},{"date":"2023-07-14","current":-1.106072,"twenty":-19.880225,"median":-4.934319,"eighty":-0.944314,"marketCap":119231289},{"date":"2023-07-20","current":-1.152762,"twenty":-19.880225,"median":-4.934319,"eighty":-0.944314,"marketCap":124264319},{"date":"2023-07-28","current":-1.054742,"twenty":-19.884768,"median":-4.808106,"eighty":-0.944232,"marketCap":113697987},{"date":"2023-08-04","current":-1.054742,"twenty":-19.884768,"median":-4.58472,"eighty":-0.944232,"marketCap":113697987},{"date":"2023-08-11","current":-1.073688,"twenty":-19.884768,"median":-4.460573,"eighty":-0.944232,"marketCap":108353405},{"date":"2023-08-18","current":-1.046432,"twenty":-19.884768,"median":-4.460573,"eighty":-0.944232,"marketCap":105602779},{"date":"2023-08-25","current":-1.208464,"twenty":-19.884768,"median":-4.460573,"eighty":-0.944232,"marketCap":121954569},{"date":"2023-09-01","current":-1.238732,"twenty":-19.884768,"median":-4.460573,"eighty":-0.944232,"marketCap":125009132},{"date":"2023-09-08","current":-1.108323,"twenty":-19.884768,"median":-4.460573,"eighty":-0.944232,"marketCap":111848676},{"date":"2023-09-15","current":-1.115853,"twenty":-19.884768,"median":-4.460573,"eighty":-0.944232,"marketCap":112608518},{"date":"2023-09-22","current":-1.070827,"twenty":-19.884768,"median":-4.460573,"eighty":-0.944232,"marketCap":108064665},{"date":"2023-09-29","current":-1.129406,"twenty":-19.884768,"median":-4.460573,"eighty":-0.944232,"marketCap":113976233},{"date":"2023-10-06","current":-1.029867,"twenty":-19.884768,"median":-4.460573,"eighty":-0.944232,"marketCap":103931127},{"date":"2023-10-13","current":-1.031524,"twenty":-19.884768,"median":-4.460573,"eighty":-0.944232,"marketCap":104098293},{"date":"2023-10-20","current":-1.048992,"twenty":-19.884768,"median":-4.460573,"eighty":-0.944232,"marketCap":105861125},{"date":"2023-10-27","current":-1.001256,"twenty":-19.898397,"median":-4.497532,"eighty":-0.943988,"marketCap":101043729},{"date":"2023-11-03","current":-1.003063,"twenty":-19.898397,"median":-4.497532,"eighty":-0.943988,"marketCap":101226091},{"date":"2023-11-10","current":-1.247119,"twenty":-19.898397,"median":-4.497532,"eighty":-0.943988,"marketCap":111003557},{"date":"2023-11-17","current":-1.36259,"twenty":-19.898397,"median":-4.497532,"eighty":-0.943988,"marketCap":121281382},{"date":"2023-11-24","current":-1.230379,"twenty":-19.898397,"median":-4.497532,"eighty":-0.943988,"marketCap":109513576},{"date":"2023-12-01","current":-1.221326,"twenty":-19.898397,"median":-4.497532,"eighty":-0.943988,"marketCap":108707770},{"date":"2023-12-08","current":-1.191433,"twenty":-19.893854,"median":-4.481639,"eighty":-0.944069,"marketCap":106047090},{"date":"2023-12-15","current":-1.144801,"twenty":-19.893854,"median":-4.481639,"eighty":-0.944069,"marketCap":101896430},{"date":"2023-12-22","current":-1.024889,"twenty":-19.893854,"median":-4.481639,"eighty":-0.944069,"marketCap":91223304},{"date":"2023-12-29","current":-0.973303,"twenty":-19.898397,"median":-4.497532,"eighty":-0.943988,"marketCap":86631731},{"date":"2024-01-05","current":-0.986455,"twenty":-19.899672,"median":-4.537043,"eighty":-0.944853,"marketCap":87802430},{"date":"2024-01-12","current":-0.985601,"twenty":-19.899672,"median":-4.537043,"eighty":-0.944853,"marketCap":87726410},{"date":"2024-01-19","current":-1.50764,"twenty":-19.900947,"median":-4.576554,"eighty":-0.944738,"marketCap":134192003},{"date":"2024-01-26","current":-1.555631,"twenty":-19.899672,"median":-4.537043,"eighty":-0.951943,"marketCap":138463591},{"date":"2024-02-02","current":-2.276255,"twenty":-19.899672,"median":-4.537043,"eighty":-0.951943,"marketCap":202604937},{"date":"2024-02-09","current":-2.238318,"twenty":-19.899672,"median":-4.537043,"eighty":-0.955293,"marketCap":199228188},{"date":"2024-02-16","current":-2.238318,"twenty":-19.899672,"median":-4.537043,"eighty":-0.960126,"marketCap":199228188},{"date":"2024-02-23","current":-2.655631,"twenty":-19.899672,"median":-4.537043,"eighty":-0.966093,"marketCap":236372427},{"date":"2024-03-01","current":-2.314193,"twenty":-19.898397,"median":-4.497532,"eighty":-0.975011,"marketCap":205981686},{"date":"2024-03-08","current":-2.105536,"twenty":-19.898397,"median":-4.497532,"eighty":-0.978684,"marketCap":187409567},{"date":"2024-03-15","current":-2.252121,"twenty":-19.898397,"median":-4.497532,"eighty":-0.988542,"marketCap":185721192},{"date":"2024-03-22","current":-2.59322,"twenty":-19.898397,"median":-4.497532,"eighty":-0.997174,"marketCap":213849871},{"date":"2024-03-28","current":-2.719718,"twenty":-19.898397,"median":-4.497532,"eighty":-1.001406,"marketCap":224281572},{"date":"2024-04-05","current":-2.382389,"twenty":-19.899672,"median":-4.537043,"eighty":-1.00682,"marketCap":196463702},{"date":"2024-04-12","current":-2.192641,"twenty":-19.899672,"median":-4.537043,"eighty":-1.012793,"marketCap":180816151},{"date":"2024-04-19","current":-1.775828,"twenty":-19.899672,"median":-4.537043,"eighty":-1.020515,"marketCap":146443696},{"date":"2024-04-26","current":-1.411873,"twenty":-19.898397,"median":-4.497532,"eighty":-1.024889,"marketCap":116430146},{"date":"2024-05-03","current":-1.606156,"twenty":-19.898397,"median":-4.497532,"eighty":-1.036402,"marketCap":132451670},{"date":"2024-05-10","current":-1.568844,"twenty":-19.898397,"median":-4.497532,"eighty":-1.046063,"marketCap":129374688},{"date":"2024-05-17","current":-2.206635,"twenty":-19.898397,"median":-4.497532,"eighty":-1.048992,"marketCap":180374771},{"date":"2024-05-24","current":-1.945733,"twenty":-19.898397,"median":-4.497532,"eighty":-1.054742,"marketCap":159048107},{"date":"2024-05-31","current":-1.760765,"twenty":-19.898397,"median":-4.497532,"eighty":-1.065992,"marketCap":143928457},{"date":"2024-06-07","current":-1.728747,"twenty":-19.898397,"median":-4.497532,"eighty":-1.069171,"marketCap":141311254},{"date":"2024-06-14","current":-1.62231,"twenty":-19.899672,"median":-4.537043,"eighty":-1.071829,"marketCap":132610824},{"date":"2024-06-21","current":-1.999763,"twenty":-19.900947,"median":-4.576554,"eighty":-1.076897,"marketCap":163464667},{"date":"2024-06-28","current":-1.848838,"twenty":-19.904773,"median":-4.593758,"eighty":-1.080615,"marketCap":151127699},{"date":"2024-07-05","current":-1.791374,"twenty":-19.904773,"median":-4.593758,"eighty":-1.082922,"marketCap":146430486},{"date":"2024-07-12","current":-1.872712,"twenty":-19.904773,"median":-4.593758,"eighty":-1.090253,"marketCap":153079197},{"date":"2024-07-15","current":-1.860775,"twenty":-19.904773,"median":-4.593758,"eighty":-1.092859,"marketCap":152103448},{"date":"2024-08-02","current":-1.829961,"twenty":-20.021497,"median":-4.971554,"eighty":-1.106719,"marketCap":149584653},{"date":"2024-08-09","current":-1.749178,"twenty":-20.021497,"median":-4.971554,"eighty":-1.116094,"marketCap":142981326},{"date":"2024-08-16","current":-2.234471,"twenty":-20.021497,"median":-4.971554,"eighty":-1.130536,"marketCap":169055626},{"date":"2024-08-23","current":-2.730787,"twenty":-20.021497,"median":-4.971554,"eighty":-1.138937,"marketCap":206605853},{"date":"2024-08-30","current":-2.56124,"twenty":-20.021497,"median":-4.971554,"eighty":-1.151477,"marketCap":193778277},{"date":"2024-09-06","current":-2.647216,"twenty":-20.021497,"median":-4.971554,"eighty":-1.159439,"marketCap":200283041},{"date":"2024-09-13","current":-2.729584,"twenty":-20.021497,"median":-4.971554,"eighty":-1.17155,"marketCap":206514878},{"date":"2024-09-20","current":-2.723872,"twenty":-20.021497,"median":-4.971554,"eighty":-1.180845,"marketCap":206082743},{"date":"2024-09-27","current":-2.428969,"twenty":-20.021497,"median":-4.971554,"eighty":-1.191314,"marketCap":183770948},{"date":"2024-10-04","current":-2.46835,"twenty":-20.021497,"median":-4.971554,"eighty":-1.205085,"marketCap":186750403},{"date":"2024-10-11","current":-2.379067,"twenty":-20.021497,"median":-4.971554,"eighty":-1.212451,"marketCap":179995456},{"date":"2024-10-18","current":-2.430172,"twenty":-20.021497,"median":-4.971554,"eighty":-1.221786,"marketCap":183861924},{"date":"2024-10-25","current":-2.338785,"twenty":-20.021497,"median":-4.971554,"eighty":-1.229796,"marketCap":176947769},{"date":"2024-10-31","current":-2.359527,"twenty":-20.021497,"median":-4.971554,"eighty":-1.234121,"marketCap":178517101},{"date":"2024-11-08","current":-2.171943,"twenty":-20.025667,"median":-4.972928,"eighty":-1.239546,"marketCap":164324889},{"date":"2024-11-15","current":-1.980795,"twenty":-20.025667,"median":-4.972928,"eighty":-1.250628,"marketCap":143286754},{"date":"2024-11-22","current":-1.884271,"twenty":-20.025667,"median":-4.972928,"eighty":-1.259277,"marketCap":136304368},{"date":"2024-11-29","current":-1.893726,"twenty":-20.025667,"median":-4.972928,"eighty":-1.279521,"marketCap":136988342},{"date":"2024-12-06","current":-1.799385,"twenty":-20.025667,"median":-4.972928,"eighty":-1.305572,"marketCap":130163947},{"date":"2024-12-13","current":-1.875801,"twenty":-20.025667,"median":-4.972928,"eighty":-1.32025,"marketCap":135691707},{"date":"2024-12-20","current":-1.897185,"twenty":-20.025667,"median":-4.972928,"eighty":-1.334395,"marketCap":137238569},{"date":"2024-12-27","current":-1.911965,"twenty":-20.025667,"median":-4.972928,"eighty":-1.342679,"marketCap":138307725},{"date":"2025-01-03","current":-2.260081,"twenty":-20.025667,"median":-4.972928,"eighty":-1.355101,"marketCap":163489740},{"date":"2025-01-10","current":-2.545303,"twenty":-20.029837,"median":-4.974302,"eighty":-1.36259,"marketCap":184122159},{"date":"2025-01-17","current":-2.33178,"twenty":-20.029837,"median":-4.974302,"eighty":-1.380196,"marketCap":168676279},{"date":"2025-01-24","current":-2.42046,"twenty":-20.029837,"median":-4.974302,"eighty":-1.380196,"marketCap":175091210},{"date":"2025-01-31","current":-2.248446,"twenty":-20.029837,"median":-4.974302,"eighty":-1.392743,"marketCap":162648064},{"date":"2025-02-07","current":-2.322975,"twenty":-20.029837,"median":-4.974302,"eighty":-1.392743,"marketCap":168039336},{"date":"2025-02-14","current":-2.368887,"twenty":-20.029837,"median":-4.974302,"eighty":-1.392743,"marketCap":171360541},{"date":"2025-02-21","current":-2.216999,"twenty":-20.029837,"median":-4.974302,"eighty":-1.392743,"marketCap":160373266},{"date":"2025-02-28","current":-1.548755,"twenty":-20.029837,"median":-4.971554,"eighty":-1.392743,"marketCap":112033806},{"date":"2025-03-07","current":-1.483974,"twenty":-20.03535,"median":-4.611961,"eighty":-1.390234,"marketCap":107347722},{"date":"2025-03-14","current":-1.626428,"twenty":-20.03535,"median":-4.402178,"eighty":-1.390234,"marketCap":117652558},{"date":"2025-03-21","current":-1.785234,"twenty":-20.03535,"median":-4.195175,"eighty":-1.390234,"marketCap":129140288},{"date":"2025-03-28","current":-1.556026,"twenty":-20.03535,"median":-3.90233,"eighty":-1.390234,"marketCap":104172804},{"date":"2025-04-04","current":-1.291127,"twenty":-20.03535,"median":-3.71845,"eighty":-1.367648,"marketCap":86438353},{"date":"2025-04-11","current":-1.070491,"twenty":-20.029837,"median":-3.173622,"eighty":-1.355101,"marketCap":71667242},{"date":"2025-04-17","current":-1.187959,"twenty":-20.029837,"median":-2.969312,"eighty":-1.355101,"marketCap":79531491},{"date":"2025-04-25","current":-1.225753,"twenty":-20.03535,"median":-2.92164,"eighty":-1.342554,"marketCap":82061728},{"date":"2025-05-02","current":-1.459327,"twenty":-20.03535,"median":-2.836103,"eighty":-1.342554,"marketCap":97699046},{"date":"2025-05-09","current":-1.385782,"twenty":-20.03535,"median":-2.767591,"eighty":-1.331885,"marketCap":92775342},{"date":"2025-05-16","current":-1.663573,"twenty":-20.03535,"median":-2.730186,"eighty":-1.331885,"marketCap":96690179},{"date":"2025-05-23","current":-1.843298,"twenty":-20.03535,"median":-2.699523,"eighty":-1.331885,"marketCap":107136145},{"date":"2025-05-30","current":-1.832708,"twenty":-20.03535,"median":-2.658756,"eighty":-1.331885,"marketCap":106520682},{"date":"2025-06-06","current":-1.552978,"twenty":-20.03535,"median":-2.631075,"eighty":-1.331885,"marketCap":90262177},{"date":"2025-06-13","current":-2.108594,"twenty":-20.03535,"median":-2.599626,"eighty":-1.331885,"marketCap":122555725},{"date":"2025-06-20","current":-2.410944,"twenty":-20.040863,"median":-2.592203,"eighty":-1.331416,"marketCap":140128893},{"date":"2025-06-27","current":-2.090925,"twenty":-19.997149,"median":-2.56124,"eighty":-1.331416,"marketCap":121528722},{"date":"2025-07-03","current":-1.676666,"twenty":-19.847558,"median":-2.526368,"eighty":-1.331416,"marketCap":97451200},{"date":"2025-07-07","current":-1.676666,"twenty":-19.816045,"median":-2.524865,"eighty":-1.331416,"marketCap":97451200}],"updateTime":1770572400827},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VXRT\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2603600091","title":"Vaxart announces publication in npj Vaccines on norovirus candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2603600091","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603600091?lang=en_us&edition=fundamental","pubTime":"2026-01-15 21:16","pubTimestamp":1768482963,"startTime":"0","endTime":"0","summary":"Vaxart (VXRT) announced the publication in npj Vaccines of data from a double-blind, placebo-controlled Phase 1 trial evaluating a single-dose, ora...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vaxart-announces-publication-in-npj-vaccines-on-norovirus-candidate-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vaxart-announces-publication-in-npj-vaccines-on-norovirus-candidate-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VXRT","BK4139","BK4568"],"gpt_icon":0},{"id":"2603600937","title":"Vaxart Reports Positive Phase 1 Results for Oral Norovirus Vaccine in Lactating Women","url":"https://stock-news.laohu8.com/highlight/detail?id=2603600937","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603600937?lang=en_us&edition=fundamental","pubTime":"2026-01-15 21:02","pubTimestamp":1768482179,"startTime":"0","endTime":"0","summary":"Vaxart Inc. has announced the publication of data from a double-blind, placebo-controlled Phase 1 clinical trial evaluating its single-dose, oral bivalent norovirus vaccine candidate in post-partum, breastfeeding women. The study, now published in npj Vaccines, demonstrated that the vaccine was safe, well-tolerated, and induced significant increases in norovirus-specific antibodies in both serum and breast milk. Additionally, norovirus-specific IgA was detected in the stool of breastfed infants, with a positive correlation observed between breast milk IgA and infant stool IgA levels, suggesting passive transfer of immunity. Topline safety and immunogenicity results were initially reported in April 2024. Vaxart plans to initiate the next clinical trial of its norovirus oral vaccine candidate in 2026, pending partnership or additional funding.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate an","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nNDL917QmW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","BK4585","BK4568","LU2095319765.USD","LU0314104364.USD","LU2210150020.SGD","SG9999014039.USD","BK4112","SG9999014021.USD","SG9999014013.SGD","SG9999014005.SGD","IE00BKPKM429.USD","NDAQ","LU2210149790.SGD","BK4588","BK4139","IE00B3QW5Z07.USD","VXRT","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2603600541","title":"Vaxart Publishes Positive Data for Its Oral Bivalent Norovirus Candidate in Lactating Women and Their Infants","url":"https://stock-news.laohu8.com/highlight/detail?id=2603600541","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603600541?lang=en_us&edition=fundamental","pubTime":"2026-01-15 21:01","pubTimestamp":1768482084,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nFWN3YG0Q1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VXRT","BK4568","BK4139"],"gpt_icon":0},{"id":"2602318386","title":"Vaxart Executives to Present at Global BioInnovation Forum","url":"https://stock-news.laohu8.com/highlight/detail?id=2602318386","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602318386?lang=en_us&edition=fundamental","pubTime":"2026-01-09 05:01","pubTimestamp":1767906084,"startTime":"0","endTime":"0","summary":"Vaxart Inc., a clinical-stage biotechnology company focused on developing oral recombinant pill vaccines, will participate in the Global BioInnovation Forum on January 13, 2026. Company leaders, including CEO Steven Lo, Founder and Chief Scientific Officer Sean Tucker, Ph.D., and Chief Medical Officer James F. Cummings, M.D., are scheduled to speak at the virtual event. The presentation will be available via webcast on Vaxart’s investor relations website for 30 days following the event.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vaxart Inc. published the original content used to generate this news brief via GlobeNewswire  on January 08, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDL8gVD4y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","SG9999014021.USD","SG9999014013.SGD","IE00B3QW5Z07.USD","VXRT","BK4568","LU2210149790.SGD","LU2210150020.SGD","LU0314104364.USD","BK4588","IE00BGHQF748.EUR","LU2095319765.USD","BK4112","BK4585","IE00BKPKM429.USD","SG9999014005.SGD","NDAQ","BK4139","SG9999014039.USD"],"gpt_icon":0},{"id":"2595278023","title":"Vaxart Relocates Headquarters and Labs Within South San Francisco","url":"https://stock-news.laohu8.com/highlight/detail?id=2595278023","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595278023?lang=en_us&edition=fundamental","pubTime":"2025-12-29 21:01","pubTimestamp":1767013283,"startTime":"0","endTime":"0","summary":"Vaxart Inc. announced it will relocate its headquarters and laboratories from 170 Harbor Way, South San Francisco, following a lease termination effective May 15, 2026. The company plans to move to another office in the South San Francisco area as part of ongoing cost reduction efforts.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vaxart Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 29, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nNDL1b6K2p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","VXRT","BK4139"],"gpt_icon":0},{"id":"2589879843","title":"Vaxart Inc. Director W. Mark Watson Acquires Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2589879843","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589879843?lang=en_us&edition=fundamental","pubTime":"2025-12-06 06:47","pubTimestamp":1764974839,"startTime":"0","endTime":"0","summary":"W. Mark Watson, Director at Vaxart Inc., has reported the acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vaxart Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 05, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nNDL2xt78q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Vaxart Inc. Director W. Mark Watson Acquires Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VXRT","BK4568"],"gpt_icon":0},{"id":"2588772529","title":"Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men","url":"https://stock-news.laohu8.com/highlight/detail?id=2588772529","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588772529?lang=en_us&edition=fundamental","pubTime":"2025-12-02 01:35","pubTimestamp":1764610500,"startTime":"0","endTime":"0","summary":"Vinay Prasad, a top regulator at the FDA, did not detail the data in the internal memo that led to the conclusion. Pfizer and BioNTech developed the COVID-19 vaccine Comirnaty.Shares of Moderna and BioNTech were down on Monday morning, likely in response to a FDA official's memo outlining a link between COVID-19 mRNA vaccines and myocarditis deaths in 10 children.Concern about that link, particularly relating to teenage boys and young men, has been a key argument against administering mRNA-based COVID vaccines in children.Vinay Prasad, the head of the Food and Drug Administration's Center for Biologics Evaluation and Research, reportedly issued a memo to staff last week that said the regulator plans to acknowledge that 10 children died after getting the vaccine. . The FDA has not publicly shared the internal research cited in the memo, although Prasad said it comes from the Vaccine Adverse Event Reporting System, which gathers reports of adverse events from the public, healthcare profe","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA","BNTX","BK4533","BK4139","IE00BLSP4452.SGD","SG9999013999.USD","BK4568","LU0985481810.HKD","LU1894683348.USD","LU1057294990.SGD","LU0306807586.USD","LU0170899867.USD","BK4551","BK4581","IE00BLSP4239.USD","VXRT","BK4535","IE0002270589.USD","DVAX","IE00B19Z3B42.SGD","LU1066051498.USD","LU1023059063.AUD","BK4532","LU0321505439.SGD","PCVX","SG9999001176.SGD","BK4592","LU0053671581.USD","SG9999011175.SGD","LU0122379950.USD","SG9999002224.SGD","SGXZ57979304.SGD","BK4585","LU0058720904.USD","SG9999003800.SGD","LU0234572021.USD","LU1066053197.SGD","LU0306806265.USD","IE00BBT3K403.USD","IE000M9KFDE8.USD","SG9999001176.USD","BK4599","BK4534","LINK.USD.HKCC","LU0225284248.USD","LU1894683264.USD","LU0225771236.USD","LU0456855351.SGD","LU1883839398.USD"],"gpt_icon":1},{"id":"2585128857","title":"Vaxart Director Elaine J. Heron Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2585128857","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585128857?lang=en_us&edition=fundamental","pubTime":"2025-11-22 02:22","pubTimestamp":1763749342,"startTime":"0","endTime":"0","summary":"Elaine J. Heron, Director, reported the acquisition of common shares of Vaxart Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vaxart Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 21, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251121:nNDLbCVw5q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Vaxart Director Elaine J. Heron Reports Acquisition of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXRT","BK4568","BK4139"],"gpt_icon":0},{"id":"2583851482","title":"Vaxart (OTC: VXRT) Q3 EPS $(0.04) Up From $(0.06) YoY, Sales $72.41M Up From $4.93M YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2583851482","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583851482?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:07","pubTimestamp":1763068044,"startTime":"0","endTime":"0","summary":"Vaxart (OTC:VXRT) Q3 EPS $(0.04) Up From $(0.06) YoY, Sales $72.41M Up From $4.93M YoY","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48850053/vaxart-otc-vxrt-q3-eps-0-04-up-from-0-06-yoy-sales-72-41m-up-from-4-93m-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Vaxart (OTC: VXRT) Q3 EPS $(0.04) Up From $(0.06) YoY, Sales $72.41M Up From $4.93M YoY","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXRT"],"gpt_icon":0},{"id":"2581886987","title":"Vaxart to Host Upcoming Conference Calls","url":"https://stock-news.laohu8.com/highlight/detail?id=2581886987","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581886987?lang=en_us&edition=fundamental","pubTime":"2025-11-07 21:00","pubTimestamp":1762520400,"startTime":"0","endTime":"0","summary":"Third quarter 2025 results conference call to be held on November 13 at 4:30 p.m. ET Stockholder fireside chat to be held on November 18 at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., Nov.  07, 2025  (G","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/07/3183604/25416/en/Vaxart-to-Host-Upcoming-Conference-Calls.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXRT","BK4181","BK4568","HST","BK4218","BK4585","BK4588","BK4139"],"gpt_icon":0},{"id":"2581709443","title":"Dynavax reports Q3 HEPLISAV-B net product revenue of $90 million and announces $100 million share repurchase program","url":"https://stock-news.laohu8.com/highlight/detail?id=2581709443","media":"Reuters","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581709443?lang=en_us&edition=fundamental","pubTime":"2025-11-06 05:04","pubTimestamp":1762376640,"startTime":"0","endTime":"0","summary":"Dynavax Technologies Corporation reported third quarter 2025 financial results, with HEPLISAV-B quarterly net product revenue at $90.0 million, a 13% year-over-year increase. The company reiterated its full year 2025 HEPLISAV-B net product revenue guidance of $315.0 to $325.0 million. Adjusted EBITDA for the full year 2025 is expected to be at least $80.0 million, up from previous guidance of at least $75.0 million. The Board of Directors authorized a new $100.0 million share repurchase program. Dynavax also announced an exclusive license agreement for Vaxart's oral COVID-19 vaccine program, including a $25.0 million upfront license fee, a $5.0 million equity investment, and potential future milestone and royalty payments. Positive topline Phase 1/2 shingles vaccine trial data was presented during the period.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nNDLbFjbFD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXRT","DVAX","BK4139","BK4568"],"gpt_icon":0},{"id":"2581709958","title":"Vaxart Secures $30 Million From Dynavax for Oral COVID-19 Vaccine License","url":"https://stock-news.laohu8.com/highlight/detail?id=2581709958","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581709958?lang=en_us&edition=fundamental","pubTime":"2025-11-06 05:00","pubTimestamp":1762376440,"startTime":"0","endTime":"0","summary":"Vaxart Inc. has announced an exclusive license agreement with Dynavax Technologies for its novel oral COVID-19 vaccine program. Under the terms of the agreement, Dynavax will pay Vaxart a $25 million upfront license fee and make a $5 million equity investment. Dynavax will receive an exclusive, worldwide license to develop and commercialize oral COVID-19 vaccines based on Vaxart's delivery platform. Vaxart will retain full operational and financial responsibility for the program through the completion of its ongoing Phase 2b clinical trial and the subsequent End of Phase 2 meeting with the FDA. After the Phase 2b data readout, Dynavax may elect to assume responsibility for future clinical development and commercialization, with Vaxart eligible for additional milestone payments and royalties.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nNDL1dMhkt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXRT","DVAX","BK4139","BK4568"],"gpt_icon":0},{"id":"2581709688","title":"Vaxart Inc - to Receive $25 Mln Upfront and $5 Mln Equity Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=2581709688","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581709688?lang=en_us&edition=fundamental","pubTime":"2025-11-06 05:00","pubTimestamp":1762376400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nTUA1CYGFJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VXRT","DVAX","BK4139","BK4568"],"gpt_icon":0},{"id":"2581709154","title":"Vaxart Inc - May Receive up to $195 Mln in Regulatory Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2581709154","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581709154?lang=en_us&edition=fundamental","pubTime":"2025-11-06 05:00","pubTimestamp":1762376400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nTUA1CYGFJ:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","BK4139","VXRT","DVAX"],"gpt_icon":0},{"id":"2581670954","title":"Vaxart Inc - Dynavax to Pay Additional $50 Mln Fee to Vaxart","url":"https://stock-news.laohu8.com/highlight/detail?id=2581670954","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581670954?lang=en_us&edition=fundamental","pubTime":"2025-11-06 05:00","pubTimestamp":1762376400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nTUA1CYGFJ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VXRT","DVAX","BK4139","BK4568"],"gpt_icon":0},{"id":"2581095977","title":"Dynavax Enters Exclusive License Agreement for Vaxart's Novel Oral Covid-19 Vaccine Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2581095977","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581095977?lang=en_us&edition=fundamental","pubTime":"2025-11-06 05:00","pubTimestamp":1762376400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nTUA1CYGFJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VXRT","DVAX","BK4139","BK4568"],"gpt_icon":0},{"id":"2576585107","title":"Vaxart to Present Research on Second-Generation Norovirus Oral Pill Vaccine Candidate at IDWeek 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2576585107","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576585107?lang=en_us&edition=fundamental","pubTime":"2025-10-20 20:00","pubTimestamp":1760961600,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Oct.  20, 2025  (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines base","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/20/3169309/25416/en/Vaxart-to-Present-Research-on-Second-Generation-Norovirus-Oral-Pill-Vaccine-Candidate-at-IDWeek-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXRT","BK4568","BK4139"],"gpt_icon":0},{"id":"2574510009","title":"Vaxart Inc - Barda Intends to Conclusively Delimit Project Agreement to Exclude Paused Work - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2574510009","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574510009?lang=en_us&edition=fundamental","pubTime":"2025-10-11 05:13","pubTimestamp":1760130792,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251010:nFWN3VR2PU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VXRT","BK4568"],"gpt_icon":0},{"id":"2574100098","title":"Vaxart Inc - 5,000 Participants in Trial to Continue Follow-up - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2574100098","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574100098?lang=en_us&edition=fundamental","pubTime":"2025-10-11 05:13","pubTimestamp":1760130792,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251010:nFWN3VR2PU:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","BK4139","VXRT"],"gpt_icon":0},{"id":"2574010006","title":"Vaxart Inc - to Continue Receiving Funding for Participant Evaluation - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2574010006","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574010006?lang=en_us&edition=fundamental","pubTime":"2025-10-11 05:13","pubTimestamp":1760130792,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251010:nFWN3VR2PU:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VXRT","BK4568"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":46,"code":"91000000","status":"200"}]}}